←Back to Expert Scholars
Translational Medicine / 转化医学TIL Therapy, Thoracic Oncology
Raghava Sundar
MBBS, PhD
🏢National University Cancer Institute Singapore🌐Singapore
Consultant and Clinician Scientist
40
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Raghava Sundar is a thoracic and GI oncologist with expertise in cellular therapies and TIL approaches for solid tumors. He leads translational studies exploring TIL feasibility and efficacy in Asian lung cancer populations. His work bridges tumor biology and early phase cell therapy trials.
Share:
🧪Research Fields 研究领域
TIL therapy
lung cancer
cell therapy
biomarkers
Asian cohorts
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Raghava Sundar 的研究动态
Follow Raghava Sundar's research updates
留下邮箱，当我们发布与 Raghava Sundar（National University Cancer Institute Singapore）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment